Antoine Hollebecque

26.4k citations
315 papers · 11.2k indexed · 8 hit papers · h-index 45
Topics
Cancer Immunotherapy and Biomarkers (59 papers)Pancreatic and Hepatic Oncology Research (52 papers)Cancer Genomics and Diagnostics (49 papers)
Journals
Nature GeneticsJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Antoine Hollebecque

293 papers receiving 11.0k citations

Hit Papers

Pemigatinib for previously treated, locally adv...201520262018202220202015201620182018250500750

Peers

Antoine Hollebecque
Comparison fields: 5 of 133
  • Oncology 6.4k
  • Surgery 3.1k
  • Pulmonary and Respiratory Medicine 3.1k
  • Molecular Biology 2.2k
  • Epidemiology 2.1k
Replace Jean‐Luc Van Laethem with:
Jean‐Luc Van Laethem Belgium
Eric Assénat France
Joon Oh Park South Korea
Jean‐Baptiste Bachet France
Gabriella Fontanini Italy
Antoine Adenis France
Theodore S. Hong United States
Martin R. Weiser United States
Ari David Baron United States
Inne H.M. Borel Rinkes Netherlands
Antoine Hollebecque relative to Jean‐Luc Van Laethem Belgium Jean‐Luc Van Laethem's profile →
Citations per field
00.5×2.6×
Jean‐Luc Van Laethem · 1×
Citations per year

Countries citing papers authored by Antoine Hollebecque

Since Specialization
Citations

This map shows the geographic impact of Antoine Hollebecque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoine Hollebecque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoine Hollebecque more than expected).

Fields of papers citing papers by Antoine Hollebecque

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoine Hollebecque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoine Hollebecque. The network helps show where Antoine Hollebecque may publish in the future.

Co-authorship network of co-authors of Antoine Hollebecque

This figure shows the co-authorship network connecting the top 25 collaborators of Antoine Hollebecque. A scholar is included among the top collaborators of Antoine Hollebecque based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoine Hollebecque. Antoine Hollebecque is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 17
3 2
4 1
5 2
6 6
7 1
8 1
9 0
10 10
11 2
12 1
13 41
14 64
15 88
16 106
17
Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1breakdown →
867
18 59
19 27
20 130

About Antoine Hollebecque

Antoine Hollebecque is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 315 papers that have together received 11.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (59 papers), Pancreatic and Hepatic Oncology Research (52 papers) and Cancer Genomics and Diagnostics (49 papers). The work is most often cited by research in Oncology (6.4k citations), Hepatology (1.1k citations) and Cancer Research (1.5k citations). Antoine Hollebecque has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Jean‐Charles Soria, Christophe Massard, Aurélien Marabelle, Stéphane Champiat, Charles Ferté, Samy Ammari, Michel Ducreux, Laurent Dercle, Sébastien Dharancy and Philippe Mathurin. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026